Trial Outcomes & Findings for A Proof-of-principle Clinical Study Investigating the Efficacy of an Experimental Dentifrice Containing Sodium Bicarbonate and Sodium Hyaluronate on Gingivitis (NCT NCT04737538)

NCT ID: NCT04737538

Last Updated: 2024-01-19

Results Overview

Number of bleeding sites were assessed by examiner by gently inserting a probe into the gingival crevice to a depth of approximately 1 millimeter (mm) and then running around the tooth (at an angle of approximately 60 degree to the long axis of the tooth), gently stretching the epithelium while sweeping from interproximal to interproximal along the sulcular epithelium. Gingival bleeding sites were assessed 30 seconds after probing. Analysis was performed using Analysis of Covariance (ANCOVA) model with study product group and gender as factors and baseline number of bleeding sites as covariate. The estimates were based on separate ANCOVA model using only the data for corresponding comparison (experimental dentifrice vs negative control dentifrice).

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

110 participants

Primary outcome timeframe

At Week 6

Results posted on

2024-01-19

Participant Flow

The study was conducted at single center in Canada.

A total of 110 participants were enrolled into the study and allocated to a randomized treatment. Of these 36 participants were randomized to the experimental dentifrice group and positive control dentifrice group each and 38 participants were randomized to the negative control dentifrice group. All the randomized participants completed the study.

Participant milestones

Participant milestones
Measure
Experimental Dentifrice
Participants were instructed to apply full ribbon of toothpaste (containing 67 percent \[%\] weight/weight \[w/w\] sodium bicarbonate, 0.2% w/w sodium hyaluronate and 0.221% w/w sodium fluoride) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Positive Control Dentifrice
Participants were instructed to apply full ribbon of toothpaste (dentifrice containing 67% w/w sodium bicarbonate and 0.221% w/w sodium fluoride) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Negative Control Dentifrice
Participants were instructed to apply full ribbon of toothpaste (dentifrice containing 0.221% w/w fluoride as sodium fluoride \[Crest Cavity Protection\]) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Overall Study
STARTED
36
36
38
Overall Study
COMPLETED
36
36
38
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Proof-of-principle Clinical Study Investigating the Efficacy of an Experimental Dentifrice Containing Sodium Bicarbonate and Sodium Hyaluronate on Gingivitis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Experimental Dentifrice
n=36 Participants
Participants were instructed to apply full ribbon of toothpaste (containing 67% w/w sodium bicarbonate, 0.2% w/w sodium hyaluronate and 0.221% w/w sodium fluoride) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Positive Control Dentifrice
n=36 Participants
Participants were instructed to apply full ribbon of toothpaste (dentifrice containing 67% w/w sodium bicarbonate and 0.221% w/w sodium fluoride) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Negative Control Dentifrice
n=38 Participants
Participants were instructed to apply full ribbon of toothpaste (dentifrice containing 0.221% w/w fluoride as sodium fluoride \[Crest Cavity Protection\]) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Total
n=110 Participants
Total of all reporting groups
Age, Continuous
37.9 Years
STANDARD_DEVIATION 14.49 • n=5 Participants
41.5 Years
STANDARD_DEVIATION 16.52 • n=7 Participants
40.3 Years
STANDARD_DEVIATION 13.41 • n=5 Participants
39.9 Years
STANDARD_DEVIATION 14.78 • n=4 Participants
Sex: Female, Male
Female
22 Participants
n=5 Participants
22 Participants
n=7 Participants
22 Participants
n=5 Participants
66 Participants
n=4 Participants
Sex: Female, Male
Male
14 Participants
n=5 Participants
14 Participants
n=7 Participants
16 Participants
n=5 Participants
44 Participants
n=4 Participants
Race/Ethnicity, Customized
African American/African Heritage
7 Participants
n=5 Participants
5 Participants
n=7 Participants
8 Participants
n=5 Participants
20 Participants
n=4 Participants
Race/Ethnicity, Customized
Asian - Central/South Asian Heritage
2 Participants
n=5 Participants
4 Participants
n=7 Participants
6 Participants
n=5 Participants
12 Participants
n=4 Participants
Race/Ethnicity, Customized
Asian - East Asian Heritage
0 Participants
n=5 Participants
0 Participants
n=7 Participants
5 Participants
n=5 Participants
5 Participants
n=4 Participants
Race/Ethnicity, Customized
Asian - South-East Asian Heritage
0 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Race/Ethnicity, Customized
White - Arabic/North African Heritage
0 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Race/Ethnicity, Customized
White - White/Caucasian/European Heritage
25 Participants
n=5 Participants
24 Participants
n=7 Participants
19 Participants
n=5 Participants
68 Participants
n=4 Participants
Race/Ethnicity, Customized
Multiple
2 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
3 Participants
n=4 Participants

PRIMARY outcome

Timeframe: At Week 6

Population: Modified Intent-to-Treat (mITT) Population: Comprised of all randomized participants who received at least one dose of the study product and provided at least one post-baseline assessment of efficacy.

Number of bleeding sites were assessed by examiner by gently inserting a probe into the gingival crevice to a depth of approximately 1 millimeter (mm) and then running around the tooth (at an angle of approximately 60 degree to the long axis of the tooth), gently stretching the epithelium while sweeping from interproximal to interproximal along the sulcular epithelium. Gingival bleeding sites were assessed 30 seconds after probing. Analysis was performed using Analysis of Covariance (ANCOVA) model with study product group and gender as factors and baseline number of bleeding sites as covariate. The estimates were based on separate ANCOVA model using only the data for corresponding comparison (experimental dentifrice vs negative control dentifrice).

Outcome measures

Outcome measures
Measure
Experimental Dentifrice
n=36 Participants
Participants were instructed to apply full ribbon of toothpaste (containing 67% w/w sodium bicarbonate, 0.2% w/w sodium hyaluronate and 0.221% w/w sodium fluoride) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Negative Control Dentifrice
n=38 Participants
Participants were instructed to apply full ribbon of toothpaste (dentifrice containing 0.221% w/w fluoride as sodium fluoride \[Crest Cavity Protection\]) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Number of Bleeding Sites at 6 Weeks (Comparison of Experimental Versus Negative Control Dentifrice)
9.5 Number of Sites
Standard Error 0.80
20.5 Number of Sites
Standard Error 0.78

SECONDARY outcome

Timeframe: At Week 6

Population: mITT Population

Number of bleeding sites were assessed by examiner by gently inserting a probe into the gingival crevice to a depth of approximately 1 mm and then running around the tooth (at an angle of approximately 60 degree to the long axis of the tooth), gently stretching the epithelium while sweeping from interproximal to interproximal along the sulcular epithelium. Gingival bleeding sites were assessed 30 seconds after probing. Analysis was performed using ANCOVA model with study product group and gender as factors and baseline number of bleeding sites as covariate. The estimates were based on separate ANCOVA model using only the data for corresponding comparison (experimental dentifrice vs positive control dentifrice).

Outcome measures

Outcome measures
Measure
Experimental Dentifrice
n=36 Participants
Participants were instructed to apply full ribbon of toothpaste (containing 67% w/w sodium bicarbonate, 0.2% w/w sodium hyaluronate and 0.221% w/w sodium fluoride) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Negative Control Dentifrice
n=36 Participants
Participants were instructed to apply full ribbon of toothpaste (dentifrice containing 0.221% w/w fluoride as sodium fluoride \[Crest Cavity Protection\]) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Number of Bleeding Sites at Week 6 (Comparison of Experimental Versus Positive Control Dentifrice)
9.8 Number of Sites
Standard Error 0.71
9.4 Number of Sites
Standard Error 0.71

SECONDARY outcome

Timeframe: At Week 6

Population: mITT Population

Number of bleeding sites were assessed by examiner by gently inserting a probe into the gingival crevice to a depth of approximately 1 mm and then running around the tooth (at an angle of approximately 60 degree to the long axis of the tooth), gently stretching the epithelium while sweeping from interproximal to interproximal along the sulcular epithelium. Gingival bleeding sites were assessed 30 seconds after probing. Analysis was performed using ANCOVA model with study product group and gender as factors and baseline number of bleeding sites as covariate. The estimates were based on separate ANCOVA model using only the data for corresponding comparison (positive control dentifrice vs negative control dentifrice).

Outcome measures

Outcome measures
Measure
Experimental Dentifrice
n=36 Participants
Participants were instructed to apply full ribbon of toothpaste (containing 67% w/w sodium bicarbonate, 0.2% w/w sodium hyaluronate and 0.221% w/w sodium fluoride) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Negative Control Dentifrice
n=38 Participants
Participants were instructed to apply full ribbon of toothpaste (dentifrice containing 0.221% w/w fluoride as sodium fluoride \[Crest Cavity Protection\]) to cover the head of toothbrush provided and to brush their teeth for one timed minute twice a day (morning and evening) for 6 weeks.
Number of Bleeding Sites at Week 6 (Comparison of Positive Versus Negative Control Dentifrice)
9.1 Number of Sites
Standard Error 0.85
20.6 Number of Sites
Standard Error 0.82

Adverse Events

Experimental Dentifrice

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Positive Control Dentifrice

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Negative Control Dentifrice

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

GSK Response Center

GlaxoSmithKline

Phone: 8664357343

Results disclosure agreements

  • Principal investigator is a sponsor employee GSK agreements may vary with individual investigators but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
  • Publication restrictions are in place

Restriction type: OTHER